<DOC>
	<DOCNO>NCT01574703</DOCNO>
	<brief_summary>Non-treatment extension study A3051123 , aim collect data cardiovascular safety participant A3051123 trial additional 28 week , allow total 52 week cardiovascular safety data collection .</brief_summary>
	<brief_title>Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders .</brief_title>
	<detailed_description>This study extension protocol study A3051123 . No treatment provide study . This study monitor cardiovascular event 28 week completion A3051123 . This study extension protocol study A3051123 . No treatment provide study . This study monitor cardiovascular event 28 week completion A3051123 .</detailed_description>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Problem Behavior</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Subjects eligible randomize study A3051123 . Participation study A3051123 cease ( ie , withdraw consent , lose followup , etc ) prior final visit study A3051123 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>smoke cessation</keyword>
	<keyword>psychiatric disease</keyword>
	<keyword>cardiovascular event</keyword>
</DOC>